Danicamtiv, a novel oral selective cardiac myosin activator, demonstrated promising beneficial effects on left ventricular systolic function coupled with marked improvements in left atrial volume and ...

In a phase 2b trial, danicamtiv, a novel cardiac myosin activator, was well tolerated and associated with improved heart ...

Understanding how cancerous cells spread from a primary tumor is important for any number of reasons, including determining the aggressiveness of the disease itself. The movement of cells into the ...

Chronic constipation (CC) remains a serious medical and social problem because the complexity of diagnosis, the lack of a single approach to treatment, and unsatisfactory treatment results. The causes ...

The Optimizer Smart implantable pulse generator, which delivers cardiac contractility modulation (CCM) therapy, is now approved by the US Food and Drug Administration for the treatment of chronic, ...

Impulse Dynamics announced it received FDA and CE Mark approval and launched its miniature next-generation cardiac contractility modulation therapy delivery system. According to a company press ...

During embryonic development, the right ventricle is formed from the secondary heart field into a crescent-shaped, thin-walled structure. 6 It is the most anterior heart chamber, sitting just beneath ...

1.1 The evidence on cardiac contractility modulation device implantation for heart failure raises no major safety concerns. However, the evidence on efficacy is inadequate in quantity and quality.

Recent studies indicate that magnetic resonance imaging (MRI) after the administration of contrast material can be used to distinguish between reversible and irreversible myocardial ischemic injury ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...